Annual Total Long Term Liabilities
$104.85 M
-$393.88 M-78.98%
31 December 2023
Summary:
Summit Therapeutics annual total long term liabilities is currently $104.85 million, with the most recent change of -$393.88 million (-78.98%) on 31 December 2023. During the last 3 years, it has risen by +$101.70 million (+3223.36%). SMMT annual total long term liabilities is now -78.98% below its all-time high of $498.73 million, reached on 31 December 2022.SMMT Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Liabilities
$5.92 M
-$690.00 K-10.43%
30 September 2024
Summary:
Summit Therapeutics quarterly total long term liabilities is currently $5.92 million, with the most recent change of -$690.00 thousand (-10.43%) on 30 September 2024. Over the past year, it has increased by +$568.00 thousand (+10.61%). SMMT quarterly long term liabilities is now -98.81% below its all-time high of $498.73 million, reached on 31 December 2022.SMMT Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SMMT Long Term Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -79.0% | +10.6% |
| 3 y3 years | +3223.4% | +65.2% |
| 5 y5 years | +2798.1% | +3.1% |
SMMT Long Term Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -79.0% | +3223.4% | -98.8% | +65.2% |
| 5 y | 5 years | -79.0% | +3223.4% | -98.8% | +87.7% |
| alltime | all time | -79.0% | -98.8% |
Summit Therapeutics Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $5.92 M(-10.4%) |
| June 2024 | - | $6.61 M(-93.9%) |
| Mar 2024 | - | $109.13 M(+4.1%) |
| Dec 2023 | $104.85 M(-79.0%) | $104.85 M(+1858.0%) |
| Sept 2023 | - | $5.36 M(-94.9%) |
| June 2023 | - | $105.84 M(+1.8%) |
| Mar 2023 | - | $103.97 M(-79.2%) |
| Dec 2022 | $498.73 M(>+9900.0%) | $498.73 M(+9140.9%) |
| Sept 2022 | - | $5.40 M(-81.5%) |
| June 2022 | - | $29.23 M(-0.4%) |
| Mar 2022 | - | $29.34 M(+556.8%) |
| Dec 2021 | $4.47 M(+41.6%) | $4.47 M(+24.6%) |
| Sept 2021 | - | $3.59 M(-14.7%) |
| June 2021 | - | $4.20 M(+25.9%) |
| Mar 2021 | - | $3.34 M(+5.8%) |
| Dec 2020 | $3.15 M(-12.8%) | - |
| Dec 2020 | - | $3.15 M(-40.0%) |
| Sept 2020 | - | $5.26 M(-14.2%) |
| Mar 2020 | - | $6.13 M(+6.7%) |
| Dec 2019 | $3.62 M(-44.9%) | - |
| Oct 2019 | - | $5.75 M(+1.9%) |
| July 2019 | - | $5.64 M(-9.5%) |
| Apr 2019 | - | $6.23 M(-5.1%) |
| Jan 2019 | $6.56 M(-86.9%) | - |
| Jan 2019 | - | $6.56 M(+16.1%) |
| Oct 2018 | - | $5.65 M(-7.1%) |
| July 2018 | - | $6.08 M(-86.6%) |
| Apr 2018 | - | $45.27 M(-9.5%) |
| Jan 2018 | $50.03 M(+32.6%) | - |
| Jan 2018 | - | $50.03 M(+74.2%) |
| Oct 2017 | - | $28.72 M(-19.8%) |
| July 2017 | - | $35.80 M(-3.5%) |
| Apr 2017 | - | $37.10 M(-1.7%) |
| Jan 2017 | $37.73 M(+359.0%) | - |
| Jan 2017 | - | $37.73 M(-2.8%) |
| Oct 2016 | - | $38.83 M(+3822.9%) |
| July 2016 | - | $989.70 K(-9.0%) |
| Apr 2016 | - | $1.09 M |
| Date | Annual | Quarterly |
|---|---|---|
| Jan 2016 | $8.22 M(+90.5%) | - |
| Jan 2016 | - | $8.22 M(+702.2%) |
| Oct 2015 | - | $1.02 M(-1.1%) |
| July 2015 | - | $1.04 M(+1.2%) |
| Apr 2015 | - | $1.02 M(-76.3%) |
| Jan 2015 | $4.32 M(+294.0%) | - |
| Jan 2015 | - | $4.32 M(+306.3%) |
| Oct 2014 | - | $1.06 M(>+9900.0%) |
| July 2014 | - | $0.00(-100.0%) |
| Jan 2014 | $1.10 M(>+9900.0%) | - |
| Jan 2014 | - | $1.10 M(>+9900.0%) |
| July 2013 | - | $0.00(0.0%) |
| Jan 2013 | $0.00(-100.0%) | - |
| Jan 2013 | - | $0.00(0.0%) |
| July 2012 | - | $0.00(-100.0%) |
| Jan 2012 | $321.90 K(-0.8%) | - |
| Jan 2012 | - | $321.90 K(-4.3%) |
| July 2011 | - | $336.40 K(+3.7%) |
| Jan 2011 | $324.40 K(-90.4%) | - |
| Jan 2011 | - | $324.40 K(-90.1%) |
| July 2010 | - | $3.29 M(-3.0%) |
| Jan 2010 | $3.39 M(-33.2%) | - |
| Jan 2010 | - | $3.39 M(-5.6%) |
| July 2009 | - | $3.59 M(-29.2%) |
| Jan 2009 | $5.08 M(-40.4%) | - |
| Jan 2009 | - | $5.08 M(-44.2%) |
| July 2008 | - | $9.10 M(+6.9%) |
| Jan 2008 | $8.51 M(+144.1%) | - |
| Jan 2008 | - | $8.51 M(-13.6%) |
| July 2007 | - | $9.86 M(+182.6%) |
| Jan 2007 | $3.49 M(+182.7%) | - |
| Jan 2007 | - | $3.49 M(+205.5%) |
| July 2006 | - | $1.14 M(-7.5%) |
| Jan 2006 | $1.23 M(>+9900.0%) | - |
| Jan 2006 | - | $1.23 M(>+9900.0%) |
| July 2005 | - | $0.00(0.0%) |
| Jan 2005 | $0.00 | - |
| Jan 2005 | - | $0.00(0.0%) |
| July 2004 | - | $0.00 |
FAQ
- What is Summit Therapeutics annual total long term liabilities?
- What is the all time high annual total long term liabilities for Summit Therapeutics?
- What is Summit Therapeutics annual total long term liabilities year-on-year change?
- What is Summit Therapeutics quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Summit Therapeutics?
- What is Summit Therapeutics quarterly long term liabilities year-on-year change?
What is Summit Therapeutics annual total long term liabilities?
The current annual total long term liabilities of SMMT is $104.85 M
What is the all time high annual total long term liabilities for Summit Therapeutics?
Summit Therapeutics all-time high annual total long term liabilities is $498.73 M
What is Summit Therapeutics annual total long term liabilities year-on-year change?
Over the past year, SMMT annual total long term liabilities has changed by -$393.88 M (-78.98%)
What is Summit Therapeutics quarterly total long term liabilities?
The current quarterly long term liabilities of SMMT is $5.92 M
What is the all time high quarterly long term liabilities for Summit Therapeutics?
Summit Therapeutics all-time high quarterly total long term liabilities is $498.73 M
What is Summit Therapeutics quarterly long term liabilities year-on-year change?
Over the past year, SMMT quarterly total long term liabilities has changed by +$568.00 K (+10.61%)